Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tarulli, A.
Right arrow Articles by Rutkove, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tarulli, A.
Right arrow Articles by Rutkove, S. B.
Related Collections
Right arrow Muscle disease
NEUROLOGY 2005;65:451-452
© 2005 American Academy of Neurology


Brief Communications

Electrical impedance myography in the bedside assessment of inflammatory myopathy

A. Tarulli, MD, G. J. Esper, MD, K. S. Lee, BS, R. Aaron, PhD, C. A. Shiffman, PhD and S. B. Rutkove, MD

From the Department of Neurology (Drs. Tarulli, Esper, Lee, and Rutkove), Harvard Medical School, Beth Israel Deaconess Medical Center, and Department of Physics (Drs. Aaron and Shiffman), Northeastern University, Boston, MA.

Address correspondence and reprint requests to Dr Rutkove, 330 Brookline Ave, TCC-810, Boston, MA 02446; e-mail: srutkove{at}bidmc.harvard.edu

Electrical impedance myography (EIM) is a new technique with potential for the noninvasive bedside assessment of myopathy. EIM was performed on the quadriceps of 10 patients with inflammatory myopathy and 10 normal subjects. The major EIM parameter, the spatially averaged phase, was 35% lower in the myositis patients and correlated with whole-body (r = 0.765, p = 0.01) and quadriceps (r = 0.673, p = 0.03) strength.


Supported by NIH grant RO1-NS42037-01A2 and grant RR01032 to the Beth Israel Deaconess Medical Center General Clinical Research Center and Harvard Center for Neurodegeneration and Repair grant AY04.

Disclosure: The authors report no conflicts of interest.

Received January 1, 2005. Accepted in final form April 28, 2005.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.